Viking Therapeutics (VKTX) Assets Average: 2015-2025
Historic Assets Average for Viking Therapeutics (VKTX) over the last 11 years, with Sep 2025 value amounting to $783.6 million.
- Viking Therapeutics' Assets Average fell 16.84% to $783.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $783.6 million, marking a year-over-year decrease of 16.84%. This contributed to the annual value of $638.4 million for FY2024, which is 137.76% up from last year.
- Per Viking Therapeutics' latest filing, its Assets Average stood at $783.6 million for Q3 2025, which was down 7.53% from $847.4 million recorded in Q2 2025.
- Viking Therapeutics' Assets Average's 5-year high stood at $957.2 million during Q2 2024, with a 5-year trough of $159.7 million in Q1 2023.
- Over the past 3 years, Viking Therapeutics' median Assets Average value was $783.6 million (recorded in 2025), while the average stood at $655.6 million.
- As far as peak fluctuations go, Viking Therapeutics' Assets Average fell by 24.69% in 2022, and later surged by 318.26% in 2024.
- Viking Therapeutics' Assets Average (Quarterly) stood at $217.6 million in 2021, then declined by 22.96% to $167.6 million in 2022, then soared by 124.08% to $375.6 million in 2023, then surged by 145.78% to $923.1 million in 2024, then dropped by 16.84% to $783.6 million in 2025.
- Its Assets Average stands at $783.6 million for Q3 2025, versus $847.4 million for Q2 2025 and $887.7 million for Q1 2025.